Reimagining the relationship between economics and health- WHO 'Health for all' provisions.
作者信息
Petrou Stavros, Jakovljevic Mihajlo
机构信息
Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
UNESCO-TWAS, Trieste, Italy.
出版信息
Cost Eff Resour Alloc. 2024 Jan 23;22(1):5. doi: 10.1186/s12962-024-00512-9.
Abstract
摘要
相似文献
1
Reimagining the relationship between economics and health- WHO 'Health for all' provisions.
Cost Eff Resour Alloc. 2024 Jan 23;22(1):5. doi: 10.1186/s12962-024-00512-9.
2
Mathematical modelling to inform 'treat all' implementation in sub-Saharan Africa: a scoping review.
J Virus Erad. 2018 Nov 15;4(Suppl 2):47-54. doi: 10.1016/S2055-6640(20)30345-9.
3
Cumulative live birth rates following a 'freeze-all' strategy: a population-based study.
Hum Reprod Open. 2019 Mar 5;2019(2):hoz004. doi: 10.1093/hropen/hoz004. eCollection 2019.
4
Fresh versus frozen embryo transfers in assisted reproduction.
Cochrane Database Syst Rev. 2021 Feb 4;2(2):CD011184. doi: 10.1002/14651858.CD011184.pub3.
5
Is 'Health for All' synonymous with 'antibiotics for all': changes in antibiotic prescribing in a performance-based financing pilot in Zanzibar.
Health Policy Plan. 2019 Nov 1;34(Supplement_2):ii28-ii35. doi: 10.1093/heapol/czz103.
6
'Take one, take all' and the Omnibus Health Care Act: significant provisions in S.B.-576 rules.
W V Med J. 1990 Apr;86(4):156-61.
7
Health for all? Pasts, presents and futures of aspirations for universal healthcare.
Soc Sci Med. 2023 Feb;319:115660. doi: 10.1016/j.socscimed.2023.115660. Epub 2023 Jan 6.
8
Increased prevalence and stable clustering rate of HIV-1 transmitted drug resistance strains after 'treat-all' in a megacity of China.
J Antimicrob Chemother. 2023 Jul 5;78(7):1795-1799. doi: 10.1093/jac/dkad175.
9
The philosophical foundations of 'health for all' and Universal Health Coverage.
Int J Equity Health. 2022 Nov 5;21(1):155. doi: 10.1186/s12939-022-01780-8.
10
The contribution of observational studies in supporting the WHO 'treat all' recommendation for HIV/AIDS.
J Virus Erad. 2018 Nov 15;4(Suppl 2):5-8. doi: 10.1016/S2055-6640(20)30346-0.
引用本文的文献
1
Evaluation of Medical Device Aging and Replacement Decisions within Hospital Environments: A User-Centered Approach.
Risk Manag Healthc Policy. 2025 Jul 1;18:2201-2215. doi: 10.2147/RMHP.S478245. eCollection 2025.
2
Critical Analysis of Markov Modeling for the Economic Evaluation of Obesity Interventions: A Systematic Review.
Risk Manag Healthc Policy. 2025 Jun 28;18:2169-2187. doi: 10.2147/RMHP.S528064. eCollection 2025.
3
Multicenter food protein-induced enterocolitis syndrome (FPIES) data collection: Leveraging a REDCap FPIES registry for improved clinical outcomes.
J Allergy Clin Immunol Glob. 2025 Jan 30;4(2):100434. doi: 10.1016/j.jacig.2025.100434. eCollection 2025 May.
4
Burden of Disease and Cost of Illness of Overweight and Obesity in Portugal.
Obes Facts. 2025;18(2):107-120. doi: 10.1159/000541781. Epub 2024 Nov 5.
5
Catastrophic health expenditure of inpatients in emerging economies: evidence from the Indian subcontinent.
Health Res Policy Syst. 2024 Aug 12;22(1):104. doi: 10.1186/s12961-024-01202-x.
6
Applying Market Basket Analysis to Determine Complex Coassociations Among Food Allergens in Children With Food Protein-Induced Enterocolitis Syndrome (FPIES).
Health Serv Res Manag Epidemiol. 2024 Jul 25;11:23333928241264020. doi: 10.1177/23333928241264020. eCollection 2024 Jan-Dec.
7
Return on investment in science: twenty years of European Commission funded research in Alzheimer's dementia, breast cancer and prostate cancer.
Cost Eff Resour Alloc. 2024 Jun 16;22(1):51. doi: 10.1186/s12962-024-00540-5.
本文引用的文献
1
Generic drug crisis in Japan and changes leading to the collapse of universal health insurance established in 1961: the case of Kobayashi Kako Co. Ltd.
Cost Eff Resour Alloc. 2023 May 31;21(1):35. doi: 10.1186/s12962-023-00441-z.
2
Incorporating carbon into health care: adding carbon emissions to health technology assessments.
Lancet Planet Health. 2022 Dec;6(12):e993-e999. doi: 10.1016/S2542-5196(22)00258-3.
3
Estimates, trends, and drivers of the global burden of type 2 diabetes attributable to PM air pollution, 1990-2019: an analysis of data from the Global Burden of Disease Study 2019.
Lancet Planet Health. 2022 Jul;6(7):e586-e600. doi: 10.1016/S2542-5196(22)00122-X.
4
NCD Countdown 2030: efficient pathways and strategic investments to accelerate progress towards the Sustainable Development Goal target 3.4 in low-income and middle-income countries.
Lancet. 2022 Mar 26;399(10331):1266-1278. doi: 10.1016/S0140-6736(21)02347-3.
5
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force.
Value Health. 2022 Jan;25(1):10-31. doi: 10.1016/j.jval.2021.10.008.
6
The Global South political economy of health financing and spending landscape - history and presence.
J Med Econ. 2021 Nov;24(sup1):25-33. doi: 10.1080/13696998.2021.2007691.
7
Mapping subnational HIV mortality in six Latin American countries with incomplete vital registration systems.
BMC Med. 2021 Jan 8;19(1):4. doi: 10.1186/s12916-020-01876-4.
8
Real GDP growth rates and healthcare spending - comparison between the G7 and the EM7 countries.
Global Health. 2020 Jul 16;16(1):64. doi: 10.1186/s12992-020-00590-3.
9
Validity and Responsiveness of Preference-Based Quality-of-Life Measures in Informal Carers: A Comparison of 5 Measures Across 4 Conditions.
Value Health. 2020 Jun;23(6):782-790. doi: 10.1016/j.jval.2020.01.015. Epub 2020 May 11.
10
Assessing the Preferences for Criteria in Multi-Criteria Decision Analysis in Treatments for Rare Diseases.
Front Public Health. 2020 May 8;8:162. doi: 10.3389/fpubh.2020.00162. eCollection 2020.
Zotero 插件